Research Compounds
A curated catalogue of research-grade peptides for in vitro laboratory use. Each entry details the compound’s receptor pathway, observed research endpoints, regulatory status, and purity specifications. All compounds are for scientific research only — not for human or veterinary consumption.
Semaglutide
GLP-1 Receptor Agonist — Research Grade
The most studied GLP-1 receptor agonist peptide in metabolic research.
Tirzepatide
Dual GIP/GLP-1 Receptor Agonist — Research Grade
A dual incretin receptor agonist for advanced metabolic pathway research.
Tesamorelin
Synthetic GHRH Analogue — Research Grade
A precision GHRH receptor agonist for growth hormone axis research.
Sermorelin
GHRH Analogue — Research Grade
A foundational GHRH analogue for pituitary and GH axis research.
Ipamorelin
GH Secretagogue Peptide — Research Grade
A selective GHS-R1a agonist for growth hormone secretagogue research.
BPC-157
Body Protection Compound — Research Grade
The most widely studied peptide in tissue repair and angiogenesis research.
TB-500
Thymosin Beta-4 Fragment — Research Grade
A thymosin-derived actin-binding peptide fragment for tissue biology research.
Bremelanotide
Melanocortin Receptor Agonist — Research Grade (PT-141)
A melanocortin receptor agonist for CNS and neuroendocrine pathway research.
GHK-Cu
Copper Peptide Complex — Research / Cosmetic Grade
A naturally occurring copper-binding tripeptide for skin biology and cosmetic research.
DSIP
Delta Sleep-Inducing Peptide — Research Grade
A neuropeptide for sleep regulation and neuroendocrine pathway research.
Epitalon
Telomerase-Related Tetrapeptide — Research Grade
A telomerase-pathway peptide for longevity and cellular biology research.
MOTS-c
Mitochondrial-Derived Peptide — Research Grade
A mitochondria-encoded peptide for metabolic and longevity biology research.
All peptide descriptions are for educational purposes only. Status designations reflect general regulatory context and may change. Always consult a qualified healthcare professional before considering any peptide-based therapy.